CN109646672A - 一种stm乌发药剂 - Google Patents
一种stm乌发药剂 Download PDFInfo
- Publication number
- CN109646672A CN109646672A CN201910021841.3A CN201910021841A CN109646672A CN 109646672 A CN109646672 A CN 109646672A CN 201910021841 A CN201910021841 A CN 201910021841A CN 109646672 A CN109646672 A CN 109646672A
- Authority
- CN
- China
- Prior art keywords
- parts
- stm
- black hair
- extract
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 23
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 230000007062 hydrolysis Effects 0.000 claims abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 8
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical group CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004471 Glycine Substances 0.000 claims abstract description 6
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 3
- 240000001341 Reynoutria japonica Species 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims 1
- 240000000249 Morus alba Species 0.000 claims 1
- 235000021028 berry Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 6
- 210000004761 scalp Anatomy 0.000 abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 3
- 208000030961 allergic reaction Diseases 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 206010013663 drug dependence Diseases 0.000 abstract description 3
- 210000003128 head Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 208000011117 substance-related disease Diseases 0.000 abstract description 3
- 238000004043 dyeing Methods 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种STM乌发药剂,STM乌发药剂包含以下原料:水20‑30份、STM细胞因子15‑25份、桑果提取物10‑20份、何首乌提取物13‑17份、黑芝麻提取物8‑12份、1,2‑戊二醇/浮游生物提取物3‑7份、甘氨酸4‑6份、水解燕麦蛋白4‑6份。本发明通过制作STM乌发药剂对白发患者进行治疗,促进黑色素形成,起到黑发的功效,本发明STM乌发药剂具有促进头部血液循环、滋养头皮、杀菌抑菌的作用,本发明STM乌发药剂成本低廉、制备简单、无副作用、无过敏反应、适用人群广、乌发效果显著,也不会产生药物依赖性。
Description
技术领域
本发明属于医疗技术领域,尤其涉及一种STM乌发药剂。
背景技术
现代社会的生活节奏日益加快,人们的工作和精神压力越来越大,因用脑过度、精神过度紧张造成头发所需营养失衡和身体过度透支的情况越来越多,白发脱发人群在增多,严重困扰着人们,影响人们的美观和身心健康,所以很多白发者在无奈和失望中不断的染发,然而大部分的染发剂都含有一种染料物质对苯二胺,它是国际公认的一种致癌物质。经常染发的人群乳腺癌、皮肤癌、白血病、膀胱癌的发病率都会增加。在美国明尼苏达州曾经做过一个调查,发现当地长期染发人群是非染发人群白血病发病率的4倍,在国内也做过一些相应的调查,发现染发人群是非染发人群的3 .8倍,这两个个数据比较接近。有关专家呼吁染发等于头顶沫毒。
发明内容
为解决上述问题,本发明的技术方案为:
一种STM乌发药剂,包含以下原料:水20-30份、STM细胞因子15-25份、桑果提取物10-20份、何首乌提取物13-17份、黑芝麻提取物8-12份、1,2-戊二醇/浮游生物提取物3-7份、甘氨酸4-6份、水解燕麦蛋白4-6份。
进一步的改进,所述STM乌发药剂包含以下原料:水25份、STM细胞因子20份、桑果提取物15份、何首乌提取15份、黑芝麻提取物10份、1,2-戊二醇/浮游生物提取物5份、甘氨酸5份、水解燕麦蛋白5份。
STM是一类具有自我复制能力的多潜能细胞,在一定条件下,它可以分化成多种功能细胞。根据STM所处的发育阶段分为胚胎STM和成体STM;根据STM的发育潜能分为三类:全能STM、多能STM和单能STM。STM是一种未充分分化,尚不成熟的细胞,具有再生各种组织器官和人体的潜在功能。
本发明通过制作STM乌发药剂对白发患者进行治疗,促进黑色素形成,起到黑发的功效,本发明STM乌发药剂具有促进头部血液循环、滋养头皮、杀菌抑菌的作用,本发明STM乌发药剂成本低廉、制备简单、无副作用、无过敏反应、适用人群广、乌发效果显著,也不会产生药物依赖性。
具体实施方式
实施例1
本发明一种STM乌发药剂,包含以下原料:水25份、STM细胞因子20份、桑果提取物15份、何首乌提取15份、黑芝麻提取物10份、1,2-戊二醇/浮游生物提取物5份、甘氨酸5份、水解燕麦蛋白5份。
实施例2
本发明一种STM乌发药剂,包含以下原料:水20份、STM细胞因子15份、桑果提取物10份、何首乌提取物13份、黑芝麻提取物8份、1,2-戊二醇/浮游生物提取物3份、甘氨酸4份、水解燕麦蛋白4份。
实施例3
本发明一种STM乌发药剂,包含以下原料:水30份、STM细胞因子25份、桑果提取物20份、何首乌提取物17份、黑芝麻提取物12份、1,2-戊二醇/浮游生物提取物7份、甘氨酸6份、水解燕麦蛋白6份。
利用本STM乌发药剂的治疗流程如下:
步骤一、取出STM乌发药剂并解冻;
步骤二、用微针将STM乌发药剂导入头皮;
步骤三、用专门的离子导入枪按摩头皮涂药处。
本发明通过制作STM乌发药剂对白发患者进行治疗,促进黑色素形成,起到黑发的功效,本发明STM乌发药剂具有促进头部血液循环、滋养头皮、杀菌抑菌的作用,本发明STM乌发药剂成本低廉、制备简单、无副作用、无过敏反应、适用人群广、乌发效果显著,也不会产生药物依赖性。
尽管本发明的实施方案已公开如上,但并不仅仅限于说明书和实施方案中所 列运用,它完全可以被适用于各种适合本发明的领域,对于熟悉本领域的人员而 言,可容易地实现另外的修改,因此在不背离权利要求及等同范围所限定的一般 概念下,本发明并不限于特定的细节。
Claims (2)
1.一种STM乌发药剂,其特征在于:包含以下原料:水20-30份、STM细胞因子15-25份、桑果提取物10-20份、何首乌提取物13-17份、黑芝麻提取物8-12份、1,2-戊二醇/浮游生物提取物3-7份、甘氨酸4-6份、水解燕麦蛋白4-6份。
2.如权利要求1所述的STM乌发药剂,其特征在于:包含以下原料:水25份、STM细胞因子20份、桑果提取物15份、何首乌提取15份、黑芝麻提取物10份、1,2-戊二醇/浮游生物提取物5份、甘氨酸5份、水解燕麦蛋白5份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910021841.3A CN109646672A (zh) | 2019-01-10 | 2019-01-10 | 一种stm乌发药剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910021841.3A CN109646672A (zh) | 2019-01-10 | 2019-01-10 | 一种stm乌发药剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109646672A true CN109646672A (zh) | 2019-04-19 |
Family
ID=66119608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910021841.3A Pending CN109646672A (zh) | 2019-01-10 | 2019-01-10 | 一种stm乌发药剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109646672A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110840784A (zh) * | 2019-12-18 | 2020-02-28 | 广东科盈科技有限公司 | 一种白发转黑发的精华液及其制备方法 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259043A (zh) * | 1997-04-04 | 2000-07-05 | 布茨公司 | 含有甲基化硅烷醇衍生物和水解植物蛋白衍生物的美容用和/或皮肤病用组合物 |
CN1364073A (zh) * | 1999-12-14 | 2002-08-14 | 埃文产品公司 | 可介导细胞间通信的护肤组合物 |
CN1785311A (zh) * | 2005-09-29 | 2006-06-14 | 高勇 | 乌发胶囊 |
CN102415971A (zh) * | 2011-12-07 | 2012-04-18 | 广州青能健日用品有限公司 | 生物环保乌发防脱洗发液及其制备方法 |
CN102551050A (zh) * | 2011-12-28 | 2012-07-11 | 黎祉扬 | 一种乌发养发黑芝麻糊 |
CN103757081A (zh) * | 2014-01-06 | 2014-04-30 | 华南理工大学 | 一种燕麦水解蛋白的工业化生产方法 |
CN103750137A (zh) * | 2013-12-26 | 2014-04-30 | 丁阳辉 | 一种防止脱发白发药膳 |
CN104473930A (zh) * | 2014-11-19 | 2015-04-01 | 天津钧濡科技有限公司 | 生发乌发水 |
CN105232577A (zh) * | 2015-11-18 | 2016-01-13 | 全亮亮 | 一种脂肪来源干细胞因子的生发技术 |
CN106728340A (zh) * | 2017-03-11 | 2017-05-31 | 广州煜明生物科技有限公司 | 具有养发功效的中药组合物及其制备方法和应用 |
CN107412556A (zh) * | 2017-04-20 | 2017-12-01 | 陈晗 | 一种乌发液及其制备方法 |
CN107550814A (zh) * | 2017-09-15 | 2018-01-09 | 安徽邦蕴物流有限公司 | 一种利用桑果提取物制备的乌发顺发洗发露生产工艺 |
CN107823007A (zh) * | 2017-12-08 | 2018-03-23 | 佛山市汇汾化妆品科技有限公司 | 一种乌发调理组合物 |
-
2019
- 2019-01-10 CN CN201910021841.3A patent/CN109646672A/zh active Pending
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259043A (zh) * | 1997-04-04 | 2000-07-05 | 布茨公司 | 含有甲基化硅烷醇衍生物和水解植物蛋白衍生物的美容用和/或皮肤病用组合物 |
CN1364073A (zh) * | 1999-12-14 | 2002-08-14 | 埃文产品公司 | 可介导细胞间通信的护肤组合物 |
CN1785311A (zh) * | 2005-09-29 | 2006-06-14 | 高勇 | 乌发胶囊 |
CN102415971A (zh) * | 2011-12-07 | 2012-04-18 | 广州青能健日用品有限公司 | 生物环保乌发防脱洗发液及其制备方法 |
CN102551050A (zh) * | 2011-12-28 | 2012-07-11 | 黎祉扬 | 一种乌发养发黑芝麻糊 |
CN103750137A (zh) * | 2013-12-26 | 2014-04-30 | 丁阳辉 | 一种防止脱发白发药膳 |
CN103757081A (zh) * | 2014-01-06 | 2014-04-30 | 华南理工大学 | 一种燕麦水解蛋白的工业化生产方法 |
CN104473930A (zh) * | 2014-11-19 | 2015-04-01 | 天津钧濡科技有限公司 | 生发乌发水 |
CN105232577A (zh) * | 2015-11-18 | 2016-01-13 | 全亮亮 | 一种脂肪来源干细胞因子的生发技术 |
CN106728340A (zh) * | 2017-03-11 | 2017-05-31 | 广州煜明生物科技有限公司 | 具有养发功效的中药组合物及其制备方法和应用 |
CN107412556A (zh) * | 2017-04-20 | 2017-12-01 | 陈晗 | 一种乌发液及其制备方法 |
CN107550814A (zh) * | 2017-09-15 | 2018-01-09 | 安徽邦蕴物流有限公司 | 一种利用桑果提取物制备的乌发顺发洗发露生产工艺 |
CN107823007A (zh) * | 2017-12-08 | 2018-03-23 | 佛山市汇汾化妆品科技有限公司 | 一种乌发调理组合物 |
Non-Patent Citations (3)
Title |
---|
HYOSEUNG SHIN等: "Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: a retrospective case series study", 《INTERNATIONAL JOURNAL OF DERMATOLOGY》 * |
范智义等: "桑椹提取物中酚类化合物的抗氧化及抗糖基化活性分析", 《食品科学》 * |
贾智慧 主编: "《精点医考临床执业医师》", 31 January 2018, 中国协和医科大学出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110840784A (zh) * | 2019-12-18 | 2020-02-28 | 广东科盈科技有限公司 | 一种白发转黑发的精华液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103721144B (zh) | 一种天然植物黑发液及其制备方法 | |
CN102178856A (zh) | 一种生发剂 | |
CN102908285B (zh) | 一种纯天然蜂王浆增白祛斑花粉膏及其生产方法 | |
CN101130010B (zh) | 一种治疗白发、脱发的内服外用药 | |
CN108272700A (zh) | 一种具有防脱育发、去屑止痒功效的组合物及其制备方法 | |
CN107582500B (zh) | 含牡丹皮的乌发养发用洗发制剂及其制备方法 | |
CN109646672A (zh) | 一种stm乌发药剂 | |
CN107669581A (zh) | 一种生姜茶麸防脱发洗发水及制备方法 | |
CN101933984A (zh) | 一种乌发、防脱发的外擦药方及其制作和使用方法 | |
CN107789520A (zh) | 一种草本营养用生发白转黑的药物 | |
CN107753380A (zh) | 一种眉毛增长促进液配方 | |
CN109106851A (zh) | 一种生发、乌发的内服中药制剂及其制备方法 | |
CN204671751U (zh) | 多功能美容面罩 | |
CN104399037A (zh) | 一种治疗脱发的药物 | |
CN200994992Y (zh) | 具磁石的面具 | |
CN204147241U (zh) | 一种激光养生梳 | |
CN103948734B (zh) | 一种植物防脱发洗发液的制备工艺 | |
CN103520486B (zh) | 一种具有延缓衰老、乌发驻颜功能的中药 | |
CN113599472A (zh) | 一种用于治疗脂溢性脱发的中药制剂及其制备方法和应用 | |
CN103169630A (zh) | 一种驱蚊洗发液 | |
CN201267601Y (zh) | 保健按摩磁梳 | |
WO2011025223A3 (ko) | 넥 케어방법 및 상기 방법을 포함하는 넥 케어키트 | |
CN209630000U (zh) | 一种克林霉素甲硝唑搽剂贴敷治疗盒 | |
CN106267575A (zh) | 多功能美容面罩 | |
CN207969820U (zh) | 一种滚珠按摩多功能梳 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190419 |